About Science Team News

Oviva Therapeutics, Inc. is a Cambrian BioPharma, Inc PipeCo

© 2023 Oviva Therapeutics, Inc. All rights reserved.

Privacy Policy Press

Back to News and Publications

See media contact

A new spinout wades into ovarian aging, armed with a seed round and experimental drugs from Mass General

3 mins to read

May 20, 2022

We want to hear from you.

Oviva Therapeutics, Inc. is a Cambrian BioPharma, Inc PipeCo
© 2022 Oviva Therapeutics, Inc. All rights reserved.

Privacy Policy Press

>